- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 31.12.25 | Profusa expands European footprint with French distributor partnership | 1 | Investing.com | ||
| 31.12.25 | Profusa expandiert in Europa: Vertriebspartnerschaft für Frankreich geschlossen | 1 | Investing.com Deutsch | ||
| 31.12.25 | Profusa, Inc.: Profusa Bolsters European Commercial Network with New French Distributor, MedSell | 1 | GlobeNewswire (USA) | ||
| 30.12.25 | Profusa Shares Rise 80% On Debt Restructuring News | 1 | RTTNews | ||
| 30.12.25 | Profusa ermöglicht Verkauf von Schuldverschreibungen im Wert von 5 Mio. US-Dollar durch Vertragsanpassung | 3 | Investing.com Deutsch | ||
| 30.12.25 | Profusa restructures senior secured convertible notes | 3 | Seeking Alpha | ||
| PROFUSA Aktie jetzt für 0€ handeln | |||||
| 30.12.25 | Profusa restrukturiert konvertierbare Anleihe für mehr Flexibilität und weniger Aktienverwässerung | 1 | Investing.com Deutsch | ||
| 30.12.25 | Profusa restructures convertible note to reduce dilution, increase flexibility | 4 | Investing.com | ||
| 30.12.25 | Profusa, Inc.: Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35 | 1 | GlobeNewswire (USA) | ||
| 30.12.25 | Profusa, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 23.12.25 | Profusa ändert Wertpapiervereinbarungen mit Ascent Partners Fund | 14 | Investing.com Deutsch | ||
| 23.12.25 | Profusa, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.12.25 | Profusa meldet Studienerfolg für Lumee-Sauerstoff-Monitoring bei pAVK | 4 | Investing.com Deutsch | ||
| 15.12.25 | Profusa's Lumee oxygen monitoring meets key endpoints in PAD study | 3 | Investing.com | ||
| 15.12.25 | Profusa, Inc.: Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025 | 272 | GlobeNewswire (Europe) | Data from FDA-advised study demonstrates Lumee Oxygen tissue monitoring is a safe and effective long-term method in PAD patients and will support potential FDA submission; strongly correlates with... ► Artikel lesen | |
| 11.12.25 | Profusa, Inc.: Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026 | 2 | GlobeNewswire (USA) | ||
| 24.11.25 | Profusa, Inc.: Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025 | 11 | GlobeNewswire (USA) | ||
| 20.11.25 | Profusa, Inc. reports Q3 results | 3 | Seeking Alpha | ||
| 19.11.25 | Profusa, Inc.: Profusa Announces Third Quarter Business and Financial Highlights | 252 | GlobeNewswire (Europe) | Recapitalization reduced net debt to $14 million as of October 31; achieved key milestones to deliver potential 2026 revenue target BERKELEY, Calif, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc.... ► Artikel lesen | |
| 19.11.25 | Profusa, Inc. - 10-Q, Quarterly Report | - | SEC Filings |
1 2 3 4 Weiter >>
67 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 46,310 | +0,46 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,180 | -2,59 % | EILMELDUNG: Fresenius Medical Care-Aktie im freien Fall - Anleger fliehen aus dem Wert! | ||
| FRESENIUS | 48,970 | +1,09 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,510 | -2,85 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PROGYNY | 26,800 | +0,49 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,200 | -0,94 % | Citizens reiterates Market Outperform rating on Privia Health stock | ||
| PROCEPT BIOROBOTICS | 33,920 | -2,30 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GENEDX | 136,55 | +0,55 % | GeneDx to launch whole genome sequencing test for fetal anomalies | ||
| HEARTFLOW | 32,580 | +4,42 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,640 | +0,71 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| BETA BIONICS | 31,490 | +0,35 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,300 | +0,14 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BILLIONTOONE | 89,44 | -5,78 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 8,870 | +5,66 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| GERRESHEIMER | 27,700 | -0,72 % | Gerresheimer Aktie: Einer der Rebound-Favoriten für 2026! | © Foto: Foto von Tima Miroshnichenko auf PexelsNach einem verheerenden Börsenjahr 2025 könnte die Gerresheimer-Aktie jetzt die große Überraschung werden.Der Pharmaverpackungs-Spezialist aus Düsseldorf... ► Artikel lesen |
PROFUSA INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,096 Euro und damit -5,70 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROFUSA INC finden Sie auf Wallstreet Online.